Why clinicians should read the laboratory's numbers
Much of a cycle's outcome is determined in the embryology laboratory, yet that work is often invisible to the clinician who counsels the couple. Fertilisation, cleavage, blastocyst formation and cryosurvival are all recorded as rates, and each rate carries information about the individual case and about the laboratory as a system. A clinician who can read these figures contributes more usefully to review.
Individual results fluctuate for reasons that have nothing to do with the laboratory: oocyte quality, sperm parameters and the clinical picture all vary between patients. Aggregated indicators, tracked across many cycles, separate this expected variation from a genuine shift in laboratory performance. Reading the two together — the single case and the running trend — is what allows a measured, rather than reactive, response to a poor result.
For this to work, everyone must mean the same thing by each figure. A fertilisation rate calculated per oocyte retrieved is not the same as one calculated per mature oocyte injected, and comparing the two is misleading. The value of an agreed framework, such as the Vienna consensus, is that it fixes the definitions, the denominators and the expected ranges, giving clinician and embryologist a common language.
The Vienna consensus framework
Published jointly by Alpha Scientists in Reproductive Medicine and the ESHRE embryology group, the Vienna consensus set out a structured list of indicators for the ART laboratory. Its purpose was not to rank clinics but to give laboratories a consistent way to monitor their own processes over time and to identify when a value has drifted outside an acceptable range.
The framework separates indicators by how they are used. Reference indicators are recorded and monitored but carry no fixed target, because they describe inputs the laboratory does not fully control. Performance indicators, by contrast, reflect laboratory process and are given two thresholds. A defined subset of the most decision-relevant performance indicators is designated as key performance indicators.
The two thresholds do different jobs. The competency value is a floor: a result below it signals that something in the process may be wrong and warrants root-cause analysis. The benchmark value is aspirational and describes what a well-run laboratory can reach. Interpreting an indicator therefore means asking not only what the number is, but where it sits between competency and benchmark, and which way it is moving.
- Reference indicators: monitored for context but without a pass-or-fail threshold, since they largely reflect the patient population.
- Performance indicators: process measures assigned a competency value and a higher benchmark value.
- Key performance indicators: the priority subset most likely to reveal a laboratory problem early.
- Competency value: the minimum level a laboratory should reliably meet; falling below it should prompt investigation.
- Benchmark value: an aspirational level that well-performing laboratories can achieve.
Key indicators and what they describe
Fertilisation rate is among the most closely watched indicators, and it is reported separately for conventional IVF and for ICSI because the two techniques behave differently. What matters clinically is normal fertilisation — the proportion of inseminated or injected oocytes showing two pronuclei. The consensus sets, for example, a competency value in the region of 60 per cent for IVF and 65 per cent for ICSI, with higher benchmark values.
Downstream indicators track how embryos progress. Cleavage rate confirms that fertilised oocytes divide as expected, while blastocyst development rate — the proportion of fertilised oocytes reaching the blastocyst stage — reflects the culture system's ability to support extended growth. Because blastocyst development is sensitive to media, temperature, pH and air quality, a fall in this rate is a sensitive early warning that culture conditions deserve scrutiny.
Implantation rate and cryosurvival sit at the interface of laboratory and clinic. Implantation is influenced by embryo transfer, endometrial factors and patient age as well as embryo quality, so it is interpreted with more caution than a purely laboratory measure. Cryosurvival, the proportion of warmed embryos surviving intact, is a cleaner reflection of vitrification technique. Each indicator must be read against its correct denominator to mean anything.
Several of these indicators depend on consistent embryo assessment. The proportion of good-quality blastocysts, for instance, is only comparable between laboratories if grading is applied the same way. The Istanbul consensus on embryo assessment provides that shared morphological language, and its use underpins any indicator that rests on a quality judgement rather than a simple count.
- Normal fertilisation rate (two pronuclei), reported separately for IVF and ICSI.
- Cleavage rate, confirming expected division of fertilised oocytes.
- Blastocyst development rate, a sensitive marker of culture conditions.
- Cryosurvival rate after vitrification and warming.
- Implantation rate, read with awareness of its clinical contributors.
KPIs in quality control and troubleshooting
Used well, KPIs turn quality control from an annual audit into continuous monitoring. Rather than waiting for a run of poor cycles, the laboratory plots each indicator over time and watches for values crossing the competency threshold or trending steadily in the wrong direction. This approach borrows from process control: the signal of interest is not a single point but a pattern across a sufficient number of cycles.
When an indicator does breach its competency value, the structured set of KPIs helps localise the cause. A fall confined to ICSI fertilisation points toward the injection step or sperm handling; a fall in blastocyst development with normal fertilisation redirects attention to the culture environment. Because the indicators map onto distinct stages of the process, the pattern of which ones move narrows the search before any equipment is touched.
Two practical cautions apply. First, indicators need enough cycles behind them; a rate from a handful of cases carries wide uncertainty and should not trigger action on its own. Second, the denominator must be stable — a shift from reporting per oocyte to per mature oocyte can move a rate without any real change. Reliable KPI review depends as much on disciplined data definitions as on the laboratory work itself.
Clinician–laboratory review and training
Indicators are most useful when clinicians and embryologists read them together. A regular joint review — comparing laboratory KPIs against clinical outcomes and the patient mix — lets each side interpret the other's data. The embryologist explains why a blastocyst rate moved; the clinician relates it to stimulation protocols or the case series. Neither view is complete alone, and the conversation itself often surfaces the explanation.
Behind the numbers stand the people who generate them. Reproducible indicators depend on trained embryologists working to defined standards, which is why formal routes such as ESHRE certification for clinical embryologists matter. Reading KPIs is itself a skill: knowing which denominator applies, how many cycles support a value, and what a given breach implies is not intuitive and benefits from structured teaching.
This is the ground a well-designed educational programme covers: how the indicators are defined, how to read a control chart, and how clinician and laboratory can review them together. ATDERA develops faculty-led educational programmes for practising clinicians in this spirit. A certificate of attendance or completion attests that a clinician took part and engaged with the material; it does not by itself confer independent competence or a licence to practise.